FDA Inspection
Nancy A. Krywonis, M.D.Nancy A. Krywonis, M.D. – FDA Inspection, Jul 23, 2021
Record Details
This FDA Inspection record concerns Nancy A. Krywonis, M.D., with an inspection on July 23, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nancy A. Krywonis, M.D.
- Inspection Date
- July 23, 2021
- Product Type
- Drugs
View Company Profile
ID · 2c851729-348c-4bd2-b672-74e266dbebd2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1147087
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 50.20Consent not obtained, exceptions do not apply
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nancy A. Krywonis, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Nancy A. Krywonis, M.D.
- FDA Inspection 997995 - 2016-12-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.